Reaction Details  Report a problem with these data
Target
Gastrin/cholecystokinin type B receptor
Ligand
BDBM50472891
Substrate
n/a
Meas. Tech.
ChEMBL_48108 (CHEMBL663095)
Ki
1.9±n/a nM
Citation
 Ursini, A; Capelli, AM; Carr, RA; Cassarà, P; Corsi, M; Curcuruto, O; Curotto, G; Dal Cin, M; Davalli, S; Donati, D; Feriani, A; Finch, H; Finizia, G; Gaviraghi, G; Marien, M; Pentassuglia, G; Polinelli, S; Ratti, E; Reggiani, AM; Tarzia, G; Tedesco, G; Tranquillini, ME; Trist, DG; Van Amsterdam, FT; Reggiani, A Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists. J Med Chem 43:3596-613 (2000) [PubMed]  Article
Target
Name:
Gastrin/cholecystokinin type B receptor
Synonyms:
CCK-2 receptor | CCK-B receptor | CCK-BR | CCKBR | CCKRB | Cholecystokinin A | Cholecystokinin receptor | Cholecystokinin-2 Receptor | GASR_HUMAN | Gastrin/cholecystokinin type B receptor
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
48445.79
Organism:
Homo sapiens (Human)
Description:
Stable expression of human CCK-2 receptors in HEK 293 cells.
Residue:
447
Sequence:
MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG
  
Inhibitor
Name:
BDBM50472891
Synonyms:
CHEMBL334020
Type:
Small organic molecule
Emp. Form.:
C33H34N4O3
Mol. Mass.:
534.6481
SMILES:
[H][C@@]12C[C@@]3([H])C[C@@]([H])(C1)C(CN1c4ccccc4N(c4ccccc4)C(=O)C(NC(=O)Nc4ccccc4)C1=O)[C@@]([H])(C2)C3 |wU:3.3,40.45,wD:6.6,1.0,TLB:10:9:5:1.8.2,THB:42:40:5:1.8.2,42:1:5:9.40.43,10:9:1.42.8:3.5.43,2:3:9:1.42.8,2:1:9:3.5.43,(13.64,-.13,;12.37,-.95,;11.18,-.03,;9.88,-.77,;8.71,.18,;9.45,-2.13,;10.62,-3.02,;9.32,-3.79,;11.8,-2.27,;10.91,-4.71,;9.86,-5.83,;10.31,-7.29,;9.32,-8.23,;7.99,-7.45,;6.65,-8.23,;6.65,-9.77,;7.99,-10.55,;9.34,-9.79,;10.27,-10.69,;9.8,-12.15,;8.3,-12.49,;7.85,-13.96,;8.88,-15.09,;10.4,-14.75,;10.85,-13.29,;11.77,-10.43,;12.69,-11.69,;12.5,-9.02,;14.02,-9.06,;14.79,-10.4,;13.99,-11.72,;16.31,-10.42,;17.07,-11.77,;16.28,-13.07,;17.03,-14.43,;18.57,-14.46,;19.36,-13.12,;18.6,-11.77,;11.8,-7.56,;12.75,-6.35,;11.48,-3.28,;12.63,-4.27,;12.75,-2.52,;10.23,-2.33,)|
Structure:
Search PDB for entries with ligand similarity: